This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Mar 27;75(6):741-2.

doi: 10.1097/01.tp.0000046766.12404.f9/.

New immunosuppressive agent: expectations and controversies

J Alsina¹, J M Grinyó

Affiliations

PMID: 12669718
DOI: 10.1097/01.tp.0000046766.12404.f9/

Review

New immunosuppressive agent: expectations and controversies

J Alsina et al. Transplantation. 2003.

. 2003 Mar 27;75(6):741-2.

doi: 10.1097/01.tp.0000046766.12404.f9/.

Authors

J Alsina¹, J M Grinyó

Affiliation

¹ Department of Nephrology, Bellvitge Hospital, Barcelona, Spain.

PMID: 12669718
DOI: 10.1097/01.tp.0000046766.12404.f9/

No abstract available

PubMed Disclaimer

Comment on

The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy.
Saunders RN, Bicknell GR, Nicholson ML. Saunders RN, et al. Transplantation. 2003 Mar 27;75(6):772-80. doi: 10.1097/00007890-200303270-00008. Transplantation. 2003. PMID: 12660500 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information